Gut Inflammation Capsules are a research formulation combining BPC-157, KPV, PEA, and Tributyrin—four compounds widely studied for their roles in gastrointestinal integrity, inflammatory signaling, and gut barrier regulation. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, KPV is a tripeptide fragment of α-MSH, PEA (palmitoylethanolamide) is a naturally occurring fatty acid amide, and Tributyrin is a prodrug of butyric acid. Together, this capsule formulation is designed strictly for controlled laboratory research applications focused on gut health mechanisms.
Prior to the study of these targeted compounds, gastrointestinal inflammation research relied largely on broad anti-inflammatory agents and nonspecific interventions. Preclinical research has demonstrated that BPC-157 may influence angiogenesis, epithelial repair, and gut barrier stability, while KPV has been studied for its role in modulating inflammatory cytokine signaling. PEA has shown relevance in inflammation and immune response regulation, and Tributyrin serves as a butyrate source studied for its effects on intestinal epithelial energy metabolism and mucosal integrity. These complementary mechanisms have made this combination a notable subject in gastrointestinal research models.
Currently, Gut Inflammation Capsules are being investigated for their potential role in studies involving intestinal inflammation models, gut barrier dysfunction, microbiome-related signaling, and epithelial repair pathways. Additional research is exploring their influence on immune modulation, oxidative stress response, and inflammatory signaling within the gastrointestinal tract. As research continues, this formulation remains a compelling subject for ongoing laboratory investigation into gut health and inflammation-related mechanisms.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Gut Inflammation Capsules are a capsule-format research formulation combining BPC-157, KPV, PEA, and Tributyrin. This blend is designed for laboratories investigating intestinal barrier signaling, inflammation-associated pathways, and recovery-adjacent mechanisms within gastrointestinal research models.
In capsule form, this formulation is commonly incorporated into protocols where oral-delivery variables, compliance simulations, or longer-horizon exposure frameworks are required. Each lot is supported by documentation intended to align with research-grade sourcing standards and internal quality management workflows.
Gut Inflammation Capsules – Research Specifications:
| Format | Capsules |
| Active Compounds | BPC-157, KPV, PEA, Tributyrin (research formulation blend) |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific data |
| Source | Chemical synthesis / formulation |
| Appearance | Encapsulated powder |
| Storage Conditions | Store sealed in a cool, dry environment, protected from heat, light, and moisture. Maintain lot integrity per laboratory SOPs. |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human consumption, clinical use, or veterinary applications. |
This formulation is engineered around a practical research objective: provide a single capsule-format variable that supports multi-pathway study design in gut-focused models. Rather than isolating a single mechanism, the blend allows investigators to evaluate coordinated signals that can intersect with epithelial integrity, inflammatory response dynamics, and gut-environment interactions.
BPC 157 is frequently studied in tissue integrity and recovery-adjacent research, and it is often discussed in the context of barrier-associated signaling. KPV is commonly referenced in inflammatory signaling discussions, while PEA is often evaluated for its relationship to immune-response modulation. Tributyrin is a butyrate-yielding compound frequently included in gut research as a tool for studying epithelial energetics and barrier-supportive pathways.
In study planning, many teams benchmark gut-focused protocols against adjacent recovery and systemic-wellness categories. For example, researchers may compare readouts against recovery-oriented references such as Thymosin Beta 4, or examine broader metabolic context using cellular energy variables like NAD.
Important Research Notice: Nordsci products are supported by lot-level analytical documentation. Certificates of Analysis are available to support internal audits, method alignment, and reproducibility across study phases.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
Gut-focused research frequently hinges on epithelial integrity and permeability-associated markers. This formulation may be used in study designs where investigators track barrier-associated signaling, structural protein dynamics, and response patterns to stressors that challenge gut lining stability.
In inflammatory signaling models, researchers may explore how coordinated variables influence cytokine-related patterns, immune-cell activity markers, or transcriptional shifts tied to inflammation response cycles. The combined nature of this formulation supports comparative designs where pathway overlap is anticipated and needs to be quantified rather than avoided.
GI research is often sensitive to environmental inputs (diet composition, stress exposure, microbiome variability, and model selection). This product may be incorporated when investigators want a standardized capsule-format variable to evaluate resilience-related readouts across controlled conditions.
In broader experimental frameworks, Gut Inflammation Capsules may be included alongside recovery and wellness references such as the Repair and Recovery Capsules category, or compared against injury-recovery staples like BPC-157, TB-500 Blend depending on the study’s endpoints. In stack-based protocols, define primary endpoints and control variables to preserve interpretability.
As a capsule-format research product, Gut Inflammation Capsules are commonly handled as a finished oral-input variable in laboratory workflows. Teams should document receiving, storage, and handling procedures in accordance with internal SOPs, study requirements, and applicable institutional controls.
Protocol Design Considerations: Gut research outcomes can be sensitive to baseline model health, feeding schedules, stress conditions, and sampling cadence. Standardize these variables early, and document them rigorously to protect data quality and reproducibility.
Note: The information above is provided as a high-level research reference only. All experimental use must be conducted by qualified personnel in appropriately equipped facilities, following applicable regulations and institutional policies.
Each lot of Gut Inflammation Capsules is accompanied by a Certificate of Analysis documenting compound identity and quality parameters. COAs are intended to support protocol documentation, internal quality assurance, and reproducibility across research cohorts.
When sourcing capsule-format GI research formulations, laboratories should prioritize clear labeling, lot traceability, and documentation availability. Nordsci Peptides provides research-grade capsule products designed to integrate cleanly into compliance-focused procurement and study documentation workflows.
IMPORTANT: Gut Inflammation Capsules are supplied exclusively for laboratory research use. Not approved for human consumption or therapeutic use. Researchers are responsible for compliance with all applicable laws, regulations, and institutional guidelines.
Browse Nordsci Products
Expandable categories. Full product glossary included for internal discovery and cross-navigation.
